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ABSTRACT
In the absence of arabinose, the AraR transcription
factor represses the expression of genes involved
in the utilization of arabinose, xylose and galactose
in Bacillus subtilis. AraR exhibits a chimeric organi-
zation: the N-terminal DNA-binding region belongs
to the GntR family and the C-terminal effector-
binding domain is homologous to the GalR/LacI
family. Here, the AraR–DNA-binding interactions
were characterized in vivo and in vitro. The effect
of residue substitutions in the AraR N-terminal
domain and of base-pair exchanges into an AraR–
DNA-binding operator site were examined by assay-
ing for AraR-mediated regulatory activity in vivo and
DNA-binding activity in vitro. The results showed
that residues K4, R45 and Q61, located in or near
the winged-helix DNA-binding motif, were the most
critical amino acids required for AraR function.
In addition, the analysis of the various mutations
in an AraR palindromic operator sequence indicated
that bases G9, A11 and T16 are crucial for AraR
binding. Moreover, an AraR mutant M34T was
isolated that partially suppressed the effect of
mutations in the regulatory cis-elements. Together,
these findings extend the knowledge on the nature
of AraR nucleoprotein complexes and provide
insight into the mechanism that underlies the
mode of action of AraR and its orthologues.
INTRODUCTION
The transcription factor AraR controls the utilization of
carbohydrates in Bacillus subtilis. The control exerted by
AraR is modulated by the presence of the effector
molecule arabinose leading to induction of expression
of at least 13 genes, comprising the arabinose (ara)
regulon, which includes the araR gene (1–4). The products
of these genes (araABDLMNPQ-abfA, araE, abnA and
xsa) include extracellular and intracellular catabolic
enzymes involved in the degradation of arabinose,
galactose and xylose containing polysaccharides, uptake
of these sugars into the cell and further catabolism of
L-arabinose and arabinose oligomers (1–3,5).
A key property of AraR is its ability to bind specific
DNA sequences in the absence of the inducer L-arabinose,
as determined by DNAse I footprinting analysis (4,6,7).
AraR recognizes and binds at least eight palindromic
operator sequences, located in the five known arabinose-
inducible promoters. Three of these promoters contain
two ara boxes: the promoter of the araABDLMNPQ-abfA
operon (boxes ORA1 and ORA2), of araE (ORE1 and
ORE2) and of xsa (ORX1 and ORX2). In the cases of the
genes araR and abnA, a single ara box is present (ORR3
and ORB1). AraR binding to the promoters displaying two
ara boxes is cooperative, requiring in phase and properly
spaced operators, and involves the formation of a small
loop in the DNA. These two mechanistically diverse
modes of action of AraR result in distinct levels of
transcriptional regulation, as cooperative binding to two
ara boxes results in a high level of repression while
interaction with a single operator allows a more flexible
control (4,6,7).
AraR is a 362 amino acid homodimeric protein that
shows a chimeric organization, consisting of two func-
tional domains with different phylogenetic origins (1,6,8):
a small N-terminal DNA-binding domain (DBD) com-
prising a winged helix–turn–helix (HTH) motif belonging
to the GntR family of transcriptional regulators (9)
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and a larger C-terminal domain homologous to that
of the GalR/LacI family of bacterial regulators and
sugar-binding proteins (10). AraR typifies one of the
six GntR-subfamilies of proteins (11,12). Currently,
there are 54 members of this rapidly growing class of
proteins, which can be found in prokaryotes [CDART
database; (13)].
Previously, a model for AraR was derived using
comparative modelling based on crystal structures of
FadR (DBD) and PurR (COOH domain) from
Escherichia coli (8). We have used random and site-
directed mutagenesis to map the functional domains
of AraR required for DNA binding, dimerization and
effector binding. The arabinose-binding pocket is com-
posed of polar and charged residues, whereas the
dimerization interface has a hydrophobic nature. In both
cases, the residues are distributed along the primary
sequence of the C-terminal domain (8). Based on crystal-
lographic studies of structurally and functionally related
proteins, binding of the effector to the COOH region in
AraR is predicted to elicit a conformational change in the
N-terminal region, leading to inhibition of binding to
operator sequences, and allowing transcription from the
arabinose-responsive promoters. This allosteric signal
involves a switching mechanism for communicating
structural changes triggered in the sensor domain to the
regulatory domain, decreasing the affinity of the latter
for DNA.
Winged helix motifs are functionally and mechanisti-
cally versatile (14). They are primarily involved in DNA
binding, but cases have been reported in which they
participate in protein–protein interactions. Monomeric,
homo- or heterodimeric protein–DNA complexes have
been characterized and revealed quite distinct modes of
binding to DNA, which can involve interactions between
the recognition helix and the wing with the major and
minor groove (15). Although the level of amino acid
identity for the DBD of all members of the GntR
superfamily is low (25%) they share this conserved
structural topology (11). Global analysis of the conserva-
tion of amino acid sequences in DNA-binding proteins
concluded that residues interacting with the DNA back-
bone establish a set of core contacts that provide stability
for homologous protein–DNA complexes, and conse-
quently are well conserved across all protein families.
On the other hand, residues that interact with DNA bases
have more variable levels of conservation (16). Previous
mutagenic studies showed that AraR residues in the
N-terminal region were required for DNA binding
because mutations in these residues abolished its regula-
tory function in vivo (8). However, the precise contribution
of the mutated amino acids to DNA-binding activity was
unclear.
To understand the specific properties of the interaction
AraR-operator sequences, we substituted amino acids, in
or near the HTH motif, which according to the model
were predicted to contact DNA. We determined the effects
of these substitutions on the ability of AraR to function
in vivo and on the DNA-binding affinities in vitro.
Conversely, mutational analysis of the AraR-binding
sites was used to determine the base-specific requirements
for transcriptional regulation in vivo and DNA binding
in vitro. These experiments gave both expected and
unexpected results, which together showed that specific
AraR residues and operator bases are crucial to achieve a
high level of regulatory activity, while others display
variable contributions to DNA binding. In addition,
an AraR mutant was isolated, which partially suppresses
the loss of regulation observed in certain mutated
DNA operators.
MATERIALS AND METHODS
Strains and growth conditions
Bacillus subtilis strains used in this work (Table 1) were
grown in Luria–Bertani (LB) medium (17) or C minimal
medium (18) and solid sugar-free agar (SFA) medium
(LabM) or LB broth solidified with 1.6% agar. Chlor-
amphenicol (5mgml1), kanamycin (10 mgml1) and ery-
thromycin (1 mgml1) were added when appropriate. The
Amy phenotype was tested by detection of starch hydro-
lysis on tryptose blood agar base medium (Difco) plates,
containing 1% of potato starch, with a I2–KI solution as
described previously (3). Escherichia coli DH5a (Gibco
BRL) or XL1-blue were used for routine molecular cloning
work and E. coli BL21 DE3 pLysS (19) for overexpression
of mutant AraR proteins. Escherichia coli strains were
grown on LB medium, with ampicillin (100mgml1),
chloramphenicol (20 mgml1), kanamycin (30 mgml1)
and IPTG (isopropyl-b-D-thiogalactopyranoside) (1mM)
added as appropriate. The B. subtilis and E. coli cells were
transformed as described previously (7).
DNAmanipulations and sequencing
DNA manipulations were carried out as described
previously (20). Restriction enzymes were purchased
from MBI Fermentas, New England Biolabs or Roche,
and used according to manufacturer’s instructions. DNA
was eluted from agarose gels using the GeneCleanII
kit (Bio101) or the GFX DNA purification kit (GE
Healthcare). PCRs were performed in a GeneAmp PCR
system 2400 (Perkin-Elmer) and PCR products purified
using QIAquick PCR purification kit (QIAgen). DNA
was sequenced using an ABI PRIS BigDye terminator
ready reaction cycle sequencing kit (Applied Biosystems).
Site-directed mutagenesis of araR
Amino acid substitutions in AraR were made by the
QuikChange (Stratagene) site-directed method using as
template plasmid pLS30 (8) and mutagenic oligonucleo-
tides carrying the modified codon in the centre (listed in
Supplementary Table 1). For R41A and H42A, a 486-bp
region containing the mutations (BglII–MluI fragment)
was subcloned in pLS30, originating plasmids pSC16
and pIF41, respectively. The linearized plasmids were
used to transform B. subtilis strain IQB350, leading to
the integration of the araR mutant alleles into the
chromosome at the amyE locus via double recombination
(Strains are listed in Table 1). Substitutions K4A,
Y5F, E30A and Q61A were generated by site-directed
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mutagenesis of pLS30, the amplified products were
ligated, linearized and used to transform B. subtilis
(Table 1). Substitution R45L was obtained by chance
when attempting to create mutation R45A (8) using an
identical procedure. Presence of the mutations was verified
by sequencing the araR allele in the resulting plasmids
or strains.
Site-directed mutagenesis of operator regions
Plasmid pLM51 (6) a pBluescript II KS (+) derivative
carrying the wild-type araABDLMNPQ-abfA promoter,
was used as template for generating single-nucleotide
substitutions in ORA1 or ORA2, using the QuikChange
(Stratagene) site-directed method and pairs of mutagenic
oligonucleotides (listed in Supplementary Table 1).
Resulting plasmids contained the following mutations
in ORA1: A1!C (pLM61), G5!T (pLM62), T6!G
(pLM58), C8!A (pLM63), G9!T [pLM54; (6)],
T10!G (pLM59), A11!C (pLM57), T16!G (pLM60);
or G9!T in ORA2 [pLM77; (7)]. The 204-bp BamHI–
EcoRI DNA fragment from these plasmids, containing
the mutagenized operator region, was then subcloned in
the same sites of pSN32 (6). This procedure generated
respectively pLM68, pLM69, pLM65, pLM70, pLM56
(6), pLM66, pLM64, pLM67 and pLM78 (7), which bear
transcriptional fusions of the araABDLMNPQ-abfA
promoter with single-point mutations to lacZ. After
linearization, plasmids were used to transform B. subtilis
IQB215, giving rise to strains where these fusions were
integrated at the amyE locus (Table 1). To analyse the
Table 1. Bacillus subtilis strains used in this work
Strain Genotype Relevant phenotype Source
IQB101 araAB0-lacZ erm Ara LacZ (1)
IQB350 araR::km araAB0-lacZ erm Ara LacZ+ pLM8!IQB101a,b
IQB351 araR::km araAB0-lacZ erm amyE::araR cat LacZ pLS24!IQB350
IQB352 araR::km araAB0-lacZ erm amyE::araR cat LacZ pLS30!IQB350
IQB355 araR::km araAB0-lacZ erm amyE::araR F37S cat LacZ+ pIF1!IQB350
IQB356 araR::km araAB0-lacZ erm amyE::araR Q61R cat LacZ+ pIF2!IQB350
IQB357 araR::km araAB0-lacZ erm amyE::araR L33S cat LacZ+ pIF3!IQB350
IQB358 araR::km araAB0-lacZ erm amyE::araR 13-65 cat LacZ+ pIF8!IQB350
IQB505 araR::km araAB0-lacZ erm amyE::araR H42A cat LacZ+ pIF41!IQB350
IQB513 araR::km araAB0-lacZ erm amyE::araR R41A cat LacZ pSC16!IQB350
IQB563 araR::km araAB0-lacZ erm amyE::araR R45A cat LacZ+ PCRmut R45Ac!IQB350
IQB564 araR::km araAB0-lacZ ermamyE::araR Q61A cat LacZ+ PCRmut Q61Ac!IQB350
IQB568 araR::km araAB0-lacZ ermamyE::araR E30A cat LacZ+ PCRmut E30Ac!IQB350
IQB571 araR::km araAB0-lacZ ermamyE::araR Y5F cat LacZ+ PCRmut Y5Fc!IQB350
IQB712 araR::km araAB0-lacZ ermamyE::araR K4A cat LacZ+ PCRmut K4Ac!IQB350
IQB530 araR::kmamyE::ORA0 -lacZ cat LacZ
+ pLM32!IQB215 (6)
IQB531 araR::kmDamyE::ORA1 (G9 !T)0 -lacZ cat LacZ
+ pLM56!IQB215 (6)
IQB532 araR::kmamyE::ORA1 (A11!C)0-lacZ cat LacZ
+ pLM64!IQB215
IQB533 araR::kmamyE::ORA1 (T6!G)0-lacZ cat LacZ
+ pLM65!IQB215
IQB534 araR::kmamyE::ORA1 (T10!G)0-lacZ cat LacZ
+ pLM66!IQB215
IQB535 araR::kmamyE::ORA1 (T16!G)0-lacZ cat LacZ
+ pLM67!IQB215
IQB536 araR::kmamyE::ORA1 (A1!C)0-lacZ cat LacZ
+ pLM68!IQB215
IQB537 araR::kmamyE::ORA1 (G5!T)0-lacZ cat LacZ
+ pLM69!IQB215
IQB538 araR::kmamyE::ORA2 (G9!T)0-lacZ cat LacZ
+ pLM78!IQB215
IQB257 araR::kmamyE::ORA1 (C8!A)0-lacZ cat LacZ
 pLM70!IQB215
IQB572 araR::kmamyE::ORA
0-lacZ cat thrC::araR erm LacZ pIF76!IQB530
IQB573 araR::kmamyE::ORA1 (G9 !T)0-lacZ cat thrC::araR erm LacZ
+ pIF76!IQB531
IQB574 araR::kmamyE::ORA1 (A11!C)0-lacZ cat thrC::araR erm LacZ
+ pIF76!IQB532
IQB575 araR::kmamyE::ORA1 (T6!G)0-lacZ cat thrC::araR erm LacZ
+ pIF76!IQB533
IQB576 araR::kmamyE::ORA1 (T10!G)0-lacZ cat thrC::araR erm LacZ
 pIF76!IQB534
IQB598 araR::kmamyE::ORA1 (C8!A)0-lacZ cat thrC::araR erm LacZ
 pIF76!IQB257
IQB599 araR::kmamyE::ORA1 (T16!G)0-lacZ cat thrC::araR erm LacZ
+ pIF76!IQB535
IQB700 araR::kmamyE::ORA1 (A1!C)0-lacZ cat thrC::araR erm LacZ
+ pIF76!IQB536
IQB701 araR::kmamyE::ORA1 (G5!T)0-lacZ cat thrC::araR erm LacZ
+ pIF76!IQB537
IQB702 araR::kmamyE::ORA2 (G9!T)0-lacZ cat thrC::araR erm LacZ
+ pIF76!IQB538
IQB583 araR::kmamyE::ORA
0-lacZ cat thrC::araR M34T erm pIF85!IQB530
IQB708 araR::kmamyE::ORA1 (G9 !T)0-lacZ cat thrC::araR M34T erm pIF85!IQB531
IQB709 araR::kmamyE::ORA1 (A11!C)0-lacZ cat thrC::araR M34T erm pIF85!IQB532
IQB582 araR::kmamyE::ORA1 (T6!G)0-lacZ cat thrC::araR M34T erm pIF85!IQB533
IQB710 araR::kmamyE::ORA1 (T10!G)0-lacZ cat thrC::araR M34T erm pIF85!IQB534
IQB704 araR::kmamyE::ORA1 (C8!A)0-lacZ cat thrC::araR M34T erm pIF85!IQB257
IQB703 araR::kmamyE::ORA1 (T16!G)0-lacZ cat thrC::araR M34T erm pIF85!IQB535
IQB705 araR::kmamyE::ORA1 (A1!C)0-lacZ cat thrC::araR M34T erm pIF85!IQB536
IQB706 araR::kmamyE::ORA1 (G5!T)0-lacZ cat thrC::araR M34T erm pIF85!IQB537
IQB707 araR::kmamyE::ORA2 (G9!T)0-lacZ cat thrC::araR M34T erm pIF85!IQB538
aThe arrows indicate transformation and point from donor DNA to recipient strain.
bTransformation was always carried out with linearized DNA.
cMutagenized pLS30 DNA was used as donor DNA (see Materials and Methods section).
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repression exerted by AraR on the ara boxes, integration
of the araR allele at the thrC locus was accomplished
by transformation with pIF76.
Isolation of AraR suppressor mutants
The insertion of a 1446-bp EcoRI–BamHI fragment from
pLS30 (8), containing the araR allele, into pDG1664
(EcoRI–BamHI) (21) yielded plasmid pIF76. This plasmid
was used as DNA template in random PCR mutagenesis,
according to the method described by Leung et al. (22).
Random PCR mutagenesis with oligos ARA6 and ARA73
amplified a 650-bp 50-end region of the araR allele. After
digestion with BamHI–Eco47III, the fragment was sub-
cloned in the same plasmid leading to the replacement of
the equivalent region of the wild-type araR allele, from
sites 227 to +251 relative to the transcription start site
(containing the promoter and the first 75 codons of the
araR gene). The recombinant plasmids were transformed
into E. coli DH5a yielding a library of araR mutations
(contained in 2200 transformants). A plasmid pool was
used in separate experiments to transform B. subtilis
strains with a araR amyE::ORA-lacZ background, in
which the ORA operator sequence carried the mutations
described above (Table 1), leading to integration of AraR
mutants at the thrC locus via double crossing-over. The
constitutive expression of lacZ due to the presence of
the mutated ara boxes leads to a Lac+ phenotype in the
receptor strains, reflected by a blue colour in SFA medium
with X-gal. To isolate mutant araR alleles suppressing the
deleterious effect of the operator mutations, we screened
for colonies displaying a weaker Lac phenotype (white/
light blue phenotype in the same medium). Chromosomal
DNA from these colonies was used as template to amplify
the mutagenized region of the araR allele, which was
subsequently cloned back into pIF76 as described above
and sequenced. The resulting plasmid, pIF85, bears a
mutation leading to a single amino acid substitution,
M34T.
b-Galactosidase assays
Bacillus subtilis strains were grown in C minimal medium
supplemented with 1% (w/v) casein hydrolysate in the
presence and in the absence of L-arabinose 0.4% (w/v)
as previously reported (1). Samples of cell culture
were collected and analysed 2 h after the addition of
L-arabinose. The ratio of b-galactosidase activity,
determined as described (17) from cultures grown for 2 h
in the presence and absence of inducer was taken as a
measure of AraR repression in the analysed strains
(Repression Index).
Imunoblotting of cell extracts
Bacillus subtilis strains were grown as for b-galactosidase
assays. Preparation of cell extracts and immunoblotting
were performed as described (8). Blots were developed
with anti-AraR-MBP2 serum (6) using the ECL detection
system (Amersham Biosciences). Protein concentration
was determined using a Bio-Rad kit.
Construction of plasmids for overexpression of AraR
mutants and protein purification
Fusion of the C-terminus of AraR variants to six
histidines in the plasmid pET30a(+) (Novagen) was
engineered, placing the genes under the control of a T7
promoter. The construction of plasmid pLS16, carrying
the wild-type allele, was described previously (7).
Construction of plasmids carrying the AraR substitutions
F37S, Q61R and L33S was accomplished in a similar
manner. Briefly, the alleles containing these mutations
were amplified with oligos ARA50 and ARA51 from the
pLS30-derivatives pIF1, pIF2 and pIF3 obtained pre-
viously (8). The 1112-bp PCR product was separately
digested with AvaI–NdeI and AvaI–HindIII, the resulting
282-bp and a 805-bp fragments were inserted in
pET30a(+) restricted with NdeI and HindIII, yielding
plasmids pIF5, pIF6 and pIF7, respectively. To introduce
mutations S53P, H42A or M34T, regions BglII–KpnI
were obtained from plasmids pIF17, pIF41 and pIF85
described above, and used to substitute the same region in
pIF7 generating pIF111, pIF123 and pIF121. For K4A,
Y5F, E30A, R45A and Q61A B. subtilis chromosomal
DNA from strains IQB712, IQB571, IQB568, IQB563 and
IQB564 was used (Table 1). PCR products were digested
with appropriate enzymes (NdeI–KpnI, BglII–KpnI or
BglII–HindIII) and used to substitute the corresponding
region in pIF7. These procedures yielded pIF124, pIF112,
pIF78, pIF74 and pIF75, respectively. The presence of the
mutations was verified by sequencing the araR alleles.
For the purification of these AraR-his6 variants, E. coli
BL21 (DE3) pLysS (19) cells transformed with the
corresponding pET30 derivatives were grown at 378C to
an optical density at 600 nm of 0.6 in 1 l of LB medium,
and then expression of the fusion proteins was induced by
addition of IPTG to 1mM. Incubation in the same
conditions continued for additional 2 h. All subsequent
steps were carried out similarly to the method described
previously (7).
Electrophoretic mobility shift assays (EMSAs)
A DNA fragment carrying the ORA1–ORA2 region was
amplified from pLM51 using primers ARA262 and
ARA263 (Supplementary Table 1). After purification,
the 126-bp PCR product was labelled with T4
Polynucleotide Kinase (MBI Fermentas) and [g-32P]
dATP, followed by extraction with phenol/chloroform
and precipitation with ethanol. Binding reactions con-
tained 12mM HEPES-KOH pH 7.6, 10mMMgCl2, 0.5%
[w/v] BSA, 1mM DTE, 10% Glycerol (v/v), 200mM
NaCl, 4mMNa2HPO4, 4mM NaH2PO4, 0.4mM EDTA,
a 200-fold molar excess of competitor DNA (polydIdC),
1 nM of labelled DNA and increasing concentrations of
wild-type or mutant AraR proteins. After incubation for
30min at room temperature, the mixture was loaded onto
a pre-run 8% polyacrylamide gel in 25mM Tris 200mM
Glycine (pH 8.9) and run at 100V for 1 h. Gels were
dried under vacuum and exposed to a Phosphorimager
screen before analysis with a Molecular Dynamics Storm
860 Imager and ImageQuant version 5.0. To determine the
dissociation constants, protein concentrations were used
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according to previous in vitro results (6) and Kd values
were obtained using the GraphPad Prism software.
For competition DNA-binding experiments, various
amounts of cold double-stranded oligonucleotides
containing single mutations in the operator sequences
(Supplementary Table 1) were added to the reaction in the
presence of 40 nM AraR. As controls, we used oligonu-
cleotides carrying the wild-type operator (ARA288 and
ARA289) or a non-specific DNA sequence with the same
length (ARA244 and ARA245). The following procedures
were made as described above. The percentage inhibition
in the presence of competitor DNA was determined
similarly to the method described by Bera et al. (23).
The radioactivity of bound DNA was quantified in the
control without competitor, and in samples containing
500-fold molar excess of the distinct competitors.
Inhibition (%)=100 [(bound)control (bound)sample/
(bound)control].
RESULTS AND DISCUSSION
In vivo effect of amino acid substitutions in the DBD of AraR
We have previously established that AraR interaction with
DNA is achieved via a 70 amino acid N-terminal domain.
These results were obtained by random and site-directed
mutagenesis based on a 3D model of the DBD derived
from the crystal structure of the E. coli regulator FadR
(8). However, many of these mutations resulted in changes
that could alter the protein structure or interfere with
DNA binding. In order to conduct a more clarifying
characterization of the role of specific AraR residues on its
DNA-binding activity, we made several amino acid
substitutions in or near the HTH motif. Residues were
chosen based on the 3D model and/or primary sequence
alignment of AraR-like proteins (8). The majority of the
substituted amino acids was predicted to contact directly
the bases of the DNA and consequently, would account
for the specificity of the interaction with operator
sequences. Positions K4, E30, R41, H42 and Q61 were
exchanged to alanine and Y5 to phenylalanine (Figure 1A
and B). The substitutions were designed to minimize local
structure disruption and probe loss of contact with the
DNA. In addition, in this work we analysed a mutation
R45L generated by chance during the construction
of mutant R45A, which was characterized in vivo in
a previous work (8). Plasmid pLS30, carrying an araR
wild-type allele, and its derivatives harbouring the
mutated araR alleles, obtained after site-directed muta-
genesis, were integrated as single copy at the amyE locus
of B. subtilis receptor strain IQB350. This strain bears an
araR null mutation (araR) and a transcriptional araAB0–
lacZ fusion (see Materials and Methods section) and
therefore expresses constitutively b-galactosidase. In the
resulting strains (Table 1), the levels of b-galactosidase
expressed from the ara operon-lacZ fusion reflect the
in vivo regulatory activity of the AraR variant encoded by
the allele integrated at the amyE locus.
The effect of each substitution was analysed by
determining the levels of accumulated b-galactosidase in
strains grown under inducing (presence of arabinose)
and non-inducing conditions (absence of arabinose).
The results are summarized in Figure 2A. The regulatory
activity was quantified as the repression index
(Figure 2A). The receptor strain IQB350 (araR
araAB0-lacZ) and IQB352, a derivative carrying the araR
wild-type allele at the amyE locus, were used as controls,
yielding repression index values of 1 and 99, respectively,
which correspond to the absence and maximal regulation
exerted by the protein. Mutation R41A had no effect
on the regulatory activity when compared to the wild type.
Therefore, although amino acid R41 is conserved among
all members of the GntR family (Figure 1A) and
establishes interactions with bases in the major groove
according to FadR-DNA data [R45 in FadR; (24)],
it is dispensable for AraR binding in vivo. Variant H42A
displayed a minimal decrease on repression activity
A F
α1 β1
α2 α3 β3β2
A
B Y5
E30
R45 H42Q61
K4
L33
F37
S53
Q61
AraR - - - - - - - - - - - - - - - ML P K Y A Q V K E E I S S W I N Q G K I L P D Q K I 28
GntR ML D S K D L L Y P A KW L S K A S T G V R V A Y E L RMR I V S G L I E S G - T I 42
FadR - - - - - - - - - - - M V I K A Q S P A G F A E E Y I I E S I WN N R F P P G T I L 32
* * *
AraR P T E N E LMQ Q F G V S R H T I R K A I G D L V S Q G L L Y S V Q G G G T F V A S 69
GntR L S E N T I A A E F S V S R S P V R E A L K I L A S E K I I R L E RMG A V V I G - 82
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Figure 1. The DNA-binding domain of AraR and localization of
mutations. (A) Sequence alignment of the N-terminal region of AraR,
FadR and GntR. Residues that are conserved in the entire family GntR
are shaded in black and residues characteristic of AraR homologous
proteins in grey (8). Positions of mutations leading to a constitutive
phenotype are boxed in yellow (8,26,29). A substitution yielding a
suppressor phenotype is boxed in red. The introduced residues in AraR
are shown above the sequence, coloured in orange when obtained
through site-directed mutagenesis and green through random mutagen-
esis (8). In FadR are coloured in light blue residues contacting the
DNA backbone and in dark blue the ones contacting the DNA bases,
according to crystallographic data (28); an asterisk below the sequence
indicates amino acids within contact distance of DNA (24). The
secondary structure (arrows representing beta-strands and bars alpha-
helices) of FadR (amino acid residues 1–73) is shown below the
alignment according to van Aalten et al. (24). The microorganisms of
source and accession numbers are: AraR from B. subtilis (P96711);
GntR from B. subtilis (P10585); FadR from E. coli (P09371).
(B) Structure of the modelled N-terminal domain of AraR (depicted
in green ribbons; only one monomer is represented for clarity; see (8)
for details) together with the DNA segment (depicted in orange
ribbons) crystallized with FadR, highlighting the site-directed (left) and
random (right) mutations displaying a constitutive phenotype. Site-
directed mutations: K4!A, Y5!F, E30!A, H42!A, R45!A and
Q61!A. Random mutations: L33!S, F37!S, S53!P and Q61!R.
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(1.6-fold). Moderate effects were observed with Y5F and
E30A, 3.3- and 4.8-fold, respectively. The more drastic
effects were seen with K4A, a 30-fold decrease in
repression, and with R45L and Q61A the regulatory
activity was completely abolished. The lack of regulation
of R45L is identical to that observed with R45A (8).
Together, the results suggest that these three residues play
the most important roles in DNA binding of the ones
analysed here.
Because the observed decrease in repression could be
the result of deficient in vivo accumulation of the mutant
proteins, as a consequence of lower stability and
proteolysis, we measured the abundance of each AraR
variant. The strains were grown as for the b-galactosidase
assays and the level of AraR estimated by western
immunobloting using equivalent amounts of their soluble
cell extracts (Figure 2B). The cellular level of all mutant
proteins was comparable to that seen with wild-type
AraR, ruling out the possibility of deregulation originated
by degradation of the repressor.
Analysis of the wild-type AraR and mutant proteins
DNA-binding affinity in vitro
The apparent affinity constants (Kd) of AraR mutants for
operator sequences were determined by EMSAs using a
32P-labelled 126-bp DNA fragment, which carried both
operators of the metabolic operon, ORA1 and ORA2
(depicted in Figure 5). Binding of AraR to this DNA
fragment was specific, as the presence of the inducer
arabinose but not xylose prevented the formation of the
protein–DNA complex (Figure 3A). Titration of 1 nM of
DNA with increasing concentrations of wild-type repres-
sor (Figure 3B) allowed the determination of an apparent
Kd 3.9 108M, which is defined as the amount of protein
necessary to shift 50% of the labelled probe (25). This
value is comparable to that previously calculated for each
individual box using DNase I quantitative footprinting
experiments, 3.4 108M and 4.7 108M for ORA1 and
ORA2, respectively (6).
All the mutant proteins that displayed an effect in vivo
were overexpressed in E. coli and purified to homogeneity
(see Materials and Methods section). Binding to DNA was
assayed by EMSA and their respective apparent affinity
constants determined (Figure 3C). Variant H42A, which
showed the minimal loss of repression in vivo (2-fold)
bound DNA with an apparent Kd of 4.1 108M, similar
to the wild-type protein. The most severe effects were
displayed by Q61A (Kd 5.5 107M), K4A and R45A,
both showing an apparent Kd41.5 106M. These three
mutants were also unable to perform a regulatory activity
in vivo. Residues K4 and H42 are completely conserved
among AraRs (8) and in a contact distance of the DNA
according to the model (Figure 1A and B), however,
mutation of these residues had different outcomes. Since
these two residues are not conserved among the members
of the entire GntR family they may contribute in very
different extents to the DNA-binding specificity of AraR-
like proteins.
R45 is a conserved amino acid in the GntR family
members. In the regulator FadR from E. coli, the
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Figure 2. In vivo characterization of AraR mutants. (A) Regulatory activity of mutant AraR proteins. b-Galactosidase activities of B. subtilis strains
carrying an araAB0–lacZ fusion and an araR allele integrated at the amyE locus were determined after growth in the absence or presence of inducer
(upper panel, in white and black bars, respectively). Amino acid substitutions (obtained by site-directed mutagenesis) are indicated for the mutated
position and amino acid substituted using the standard one-letter designation. The repression index (lower panel), calculated as the ratio between
values obtained in the presence and in the absence of inducer, reflects the regulation exerted by each protein variant. Values are the average of three
independent experiments, each assayed in duplicate. Error bars represent the SD. M.U.—Miller Units. Results obtained with strain harbouring wild-
type AraR and null-mutant were previously reported (8). (B) AraR accumulation in the cell by western immunoblot analysis. Equal amounts of the
soluble fractions of cell extracts obtained from the same B. subtilis strains grown in the absence () or presence (+) of inducer, were prepared as
described in the Materials and Methods section.
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substitution of the corresponding residue (R49) has also a
drastic effect in vivo (26). Moreover, the crystal structure
of the FadR–DNA complex (27,28) shows that R49
locates in the recognition helix of the winged HTH and
interacts with a phosphate group, not specifically a base.
According to the predictions of the tertiary structure of
AraR, R45 is also located in the recognition helix
(Figure 1B), which is generally more responsible for the
interaction with DNA, in particular the positively charged
residues. Q61 belongs to the predicted wing of the DNA-
binding motif (Figure 1A and B). The corresponding
residue in both FadR and in GntR from B. subtilis is
also positively charged (Figure 1A) and substitutions
led to loss of DNA-binding ability (26,29). In FadR, H65
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Figure 3. Binding of AraR to araABDLMNPQ-abfA promoter (operators ORA1-ORA2) in EMSA. AraR was incubated with the 5
0-end-labelled
probe (1–2 nM) and the protein–DNA complexes resolved by electrophoresis on native 8% polyacrylamide gels. Protein concentrations were
calculated considering a pure dimeric protein. (A) Specificity controls for AraR binding. AraR (60 nM) was incubated with the DNA probe in the
presence of L-arabinose or D-xylose (15mM). (B) The indicated amounts of wild-type AraR were used in the binding reactions (left). Densitometric
quantification of the bands corresponding to free DNA and protein–DNA complex allowed the determination of the affinity constant (right)
(see Materials and Methods section). The values shown represent the average and standard deviation of at least three independent assays, with an
intrinsic error530%. (C) Effect of AraR substitutions on binding to DNA probe. The indicated concentrations of the mutant proteins were used in
EMSA and determination of Kd was made as described above.
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is part of the wing and makes specific contacts with an
adenine (24,28).
Intermediate decreases of DNA binding were observed
with Y5F and E30A, with Kd 2.0 107M and
2.3 107M, respectively, similarly to that seen in vivo.
Therefore, these exchanges led to a comparable effect both
in vivo and in vitro (Figures 2 and 3). Moreover, the nature
of the mutation Y5F revealed the importance of the
OH group in the interaction with DNA. Both residues
are conserved in the GntR-family proteins, and the
corresponding residues in FadR, A9 and E34, were
shown to contact the DNA backbone (24,28). The latter
also contacts nearby amino acids, contributing presum-
ably to the stabilization of residues that interact specifi-
cally with the DNA bases.
Additionally, four other AraR mutants, L33S, F37S,
S53P and Q61R, obtained by random mutagenesis and
characterized in vivo in a previous work [(8); Figure 1B),
were studied by EMSA. Both substitutions F37S and S53P
had led to derepression in vivo, of 24- and 2-fold, and in
mutant L33S the regulatory activity was almost comple-
tely abolished (8). These values could be explained by the
observed instability of the proteins (8). However, purified
mutants F37S and S53P showed decreased DNA-binding
affinities, Kd 7.4 107M and 6.5 107M, respectively,
that may also contribute to the deregulation in vivo. These
results could be explained by the nature and localization
of these substitutions, which suggest implications in the
folding of the DBD. Overexpression and purification of
L33S yielded only small amounts of protein. Nevertheless,
at the maximal concentration that we could use in EMSA
assays, 50 nM of the mutant, no DNA binding was
observed (data not shown).
Interestingly, while the Q61A substitution completely
abolished regulation in vivo and DNA binding in vitro,
the change to arginine in the same position showed only a
1.6-fold decrease of regulatory activity in vivo (8), and
the affinity to the DNA probe in vitro, Kd 3.1 108M,
was even slightly higher than that displayed by wild-
type AraR. Noteworthy, in GntR the inverse of AraR
mutation Q61R (i.e. GntR R75Q) leads to a significant
loss of regulation in vivo (29). Based on these observations,
we may speculate that the rise of positive charge as
a result of AraR substitution Q61R increased the overall
(non-specific) affinity for DNA, leading in vivo to
a titration of the protein.
In summary, K4, R45 and Q61, were the most critical
AraR residues in achieving specific DNA binding, and Y5
and E30 also play an important role, and overall there was
a good correlation between the effects of the mutations in
the binding affinities to the ara operon promoter in vitro
and in the regulatory activity in vivo.
Effect of base-pairs mutations in the operator sequences
on transcriptional regulation by AraR
AraR recognizes and binds at least eight palindromic
operator sequences, located in the five known arabinose-
inducible promoters. Three of these promoters contain
two ara boxes: the promoter of the ara metabolic operon
(boxes ORA1 and ORA2), of araE (ORE1 and ORE2) and
of xsa (ORX1 and ORX2). In the cases of the genes araR
and abnA, a single ara box is present (ORR3 and ORB1).
AraR binding to the promoters displaying two
ara boxes is cooperative and involves the formation of a
small loop in the DNA. In fact, for full in vivo repression,
communication between repressor molecules bound to
two properly spaced operators is required, as shown by
the analysis of mutations designed to prevent cooperative
binding of AraR (6,7). An alignment of the eight ara
boxes, identified by DNase I footprinting and/or
mutagenesis, showed the 16-bp consensus sequence
50-ATTTGTACGTACAAAT-30 and highlighted the
conserved nucleotides at each position (Figure 4A).
This operator consensus presents the typical signature
for cis-acting elements recognized by GntR family
members 50-(N)x-GT-N(0-15)-AC-(N)x-30 (11).
In a previous work, we showed that G9 is important for
AraR binding because the substitution G9!T in
both boxes ORA1 and ORA2 caused defect in the
regulatory activity of AraR in vivo and prevented
cooperative binding (6). To further investigate which
nucleotides within the consensus sequence were necessary
for protein binding, single-nucleotide exchanges were
made in ORA1 at the promoter of the ara operon. The
most conserved bases were substituted and mutations were
designed to introduce transversions from AT to CG and
CG to AT: A1!C, G5!T, T6!G, C8!A, T10!G,
A11!C and T16!G. The mutated promoters transcrip-
tional fused to the lacZ gene were independently
integrated at the amyE locus of the B. subtilis receptor
strain (see Materials and Methods section and Table 1).
Strain IQB572, bearing a transcriptional fusion to the
wild-type operator (araR amyE::ORA(wt)-lacZ
thrC::araR) was used as a control to assay the repres-
sion exerted by AraR. The levels of accumulated
b-galactosidase activity measured in all strains are
shown in Figure 4B. Mutations having the most drastic
effect on AraR binding were G9!T, both in ORA1 and
ORA2 [as previously determined; (7)], A11!C and
T16!G, leading to a decrease in the regulatory activity
49-fold compared to the control. A moderate effect of
deregulation, varying from 2.4- to 4.4-fold, was observed
for A1!C, G5!T and T6!G, and substitution T10!G
had no effect in vivo.
Surprisingly, C8!A abolished lacZ expression both in
inducing and non-inducing conditions. One possibility to
explain this result would be an increase in the affinity of
AraR for the mutated operator leading to a tight binding
of the repressor (even in the presence of arabinose), thus
preventing transcription by RNA polymerase. To test this
hypothesis, we investigated the Lac phenotype in araR-
null mutants (araR) bearing the transcriptional fusion
ORA1(C8!A)–lacZ and ORA(wt)–lacZ, strains IQB257 and
IQB530 (Table 1), respectively. The results obtained in
solid medium with X-gal and arabinose indicated that the
lack of lacZ expression in mutant C8!A (Position +4,
relative to the transcriptional start site) was independent
of the presence of AraR (data not shown) suggesting
that the mutation may affect transcription initiation by
RNA polymerase.
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AnalysisofoperatormutationsonAraR–DNAaffinity in vitro
The effect of the operator mutations was also analysed
in vitro by EMSA competition assays. The experiments
were performed in the presence of 1 nM of the ORA1–
ORA2 DNA probe described above, 40 nM of AraR, and
increasing concentrations of a double-stranded 38-bp
competitor oligonucleotide (50–500 nM) containing the
wild-type or the described mutations in ORA1 or ORA2. In
addition, oligonucleotides carrying all possible substitu-
tions at the highly conserved base pairs, G9, A10 and T16
were also used. We compared the ability of these cold
DNAs to titrate binding of AraR to the labelled probe,
reflected in the decrease of the intensity of the protein–
DNA complex band. The wild-type ORA1 box was able to
compete for AraR binding in a concentration-dependent
manner, with a 79% loss of band shift at 500-fold excess
competitor DNA (Figure 5A). In contrast, a non-specific
oligonucleotide (equivalent in length; Supplementary
Table 1) used as control disrupted only 18% of the
binding (data not shown). Inhibition of binding in the
presence of 500 nM of the different competitors was
quantified and the results are summarized in Figure 5B.
The DNA containing mutation T10!G in ORA1
competed in levels similar to that obtained for the wild-
type box (68 and 79% inhibition, respectively). In
contrast, AraR was unable to bind the boxes with single
base-pair substitutions in G9, either to T (the mutation
tested in vivo, previously), to A and C (inhibition values
between 21 and 16%). A notorious decrease in binding
to A11!C was also observed, which was more pro-
nounced when A was exchanged for G or T. However,
oligonucleotides containing a mutation at T16 (either to G,
A or C) were still able to partially compete for the
repressor. The three mutations, A1!C, G5!T and
T6!G, leading to a partial de-repression in vivo also
showed an intermediate effect. Taken together, the results
indicate a good correlation between the in vivo and
in vitro, but the exchanges at T16 and the mutation
A11!C, comparatively to the regulatory activity in vivo
were expected to bind to AraR less tightly. This could be
due to the more reduced sensitivity of the competition
assays. Interestingly, the mutation C8!A, that affected
transcription even in the presence of inducer, did not
compete (23%) for AraR, indicating that the mutation has
an effect on AraR binding that could not be tested in vivo.
In previous work, a search for AraR operator sequences
in the B. subtilis genome (6,30) identified a putative
binding sequence in the open reading frame ydjK
[identified as a myo-inositol transporter, iolT; (31)].
The sequence 50-TTTTTACGTACAATT-30 [+27 relative
to the translation start site; (31)] displayed only two
deviations (underlined) from the consensus sequence:
A1 and G5. Construction and analysis of transcriptional
fusions of the promoter region and 50-end of ydjK to lacZ
showed that expression is not AraR dependent, thus the
potential operator is not functional in vivo (Ina´cio,J.M.
and I.S.-N., unpublished data). To determine the ability of
AraR to bind this sequence in vitro, competition assays
were performed as described above but no competition
was detected (Figure 5B). Since T at Position 1 is present
in functionally active AraR boxes (Figure 4A) these
observations suggest, in accordance to the mutagenic
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Figure 4. Ara operator sequences. (A) Alignment of the eight AraR boxes and a picture representing the conservation of bases at each position in the
inferred consensus 16-bp palindromic operator sequence [generated by WebLogo 2.8.2 software (33)]. Ara boxes are located in the promoter of the
araABDLMNPQ-abfA metabolic operon (ORA1 and ORA2), araE (ORE1 and ORE2), araR (ORR3), xsa (ORX1 and ORX2) and abnA (ORB1). The
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are indicated, and the new base is shown above. (B) Effect of ara box mutations on in vivo regulation by AraR. b-Galactosidase activities were
determined in B. subtilis strains carrying ORA–lacZ fusions integrated at the amyE locus and wild-type araR at the thrC locus grown in the absence
or presence of arabinose (upper panel, in white and black bars, respectively). The repression index (lower panel) reflects the regulation exerted
on each ara box (Figure 2). Nucleotide substitutions (obtained by site-directed mutagenesis) are indicated for the mutated position in the
ara consensus box (Figure 4A). Values are the average of three independent experiments, each assayed in duplicate. Error bars represent the SD.
M.U.—Miller Units.
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analysis described above, that G at Position 5 plays an
important role in AraR binding.
In conclusion, we found that bases in both arms of the
palindrome of the AraR boxes are involved in AraR–
DNA contacts. The in vivo and in vitro studies together
with sequence analysis of the eight functionally active
AraR B. subtilis boxes indicated that bases G9, A11 and
T16 are crucial for AraR binding, and that A1 and T6
play also an important role. Furthermore, Position 5
required a purine (Pu) for functionality in vivo, and
sequence analysis suggested that the corresponding
mirror base (Position 12) in the other arm of the
palindrome is always a pyrimidine (Py). An alignment
of all putative AraR-binding sequences based on a
search of the consensus 50-ATTTGTACGTACAAAT-30
in genomes of bacteria from the Bacillus/Clostridium
group that contain AraR orthologues also highlighted
the majority of the invariable positions: Pu5, T6 and the
correspondent mirror A11, Py12 and G9 at the centre of
the palindrome (Supplementary Figure 1).
MutationM34T partially restores AraR binding to mutated
DNA operators both in vivo and in vitro
In order to isolate AraR mutants that could suppress
the loss of regulation caused by the single nucleotide
substitutions in the ara boxes, an in vivo screening method
was developed (see Materials and Methods section).
Briefly, random mutagenesis of the 50-end of the araR
allele was performed by PCR and the resulting library
of plasmids carrying the mutated alleles was used to
transform B. subtilis strains, allowing its integration at
the non-essential thrC locus via a double-crossover event.
The receptor strains possessed a araR amyE::ORA-
lacZ background, and carried different mutations in
the ORA operator sequence (Table 1). The constitutive
expression of lacZ due to the inability of the wild-type
AraR to bind the mutated operator leads to a Lac+
phenotype in the absence of inducer. However, if the
integrated mutant araR allele encodes a protein that
suppressed the deleterious effect of the operator mutation
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A B
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ORA1 T6→G 36 ± 11
ORA1 C8→A 23 ± 3
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ORA1 T10→G 68 ± 12 
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Figure 5. In vitro analysis of AraR binding to mutated ara boxes. (A) Competition EMSA experiments using double-stranded oligonucleotides
containing mutated ara boxes. AraR (40 nM) was incubated with the 32P-labelled ORA1–ORA2 region (1 nM) in the presence or absence of the
indicated molar excess of 38-bp ds oligonucleotide competitors with wild type or the mutated ara boxes shown above. Protein–DNA complexes were
resolved by electrophoresis in 8% polyacrylamide gels. Representative results are shown. (B) Quantification of the inhibition of AraR binding to
wild-type operator sequence in the presence of competitor DNA. The values represent the percentage of inhibition of AraR binding to the labelled
DNA probe observed in the presence of 500-fold molar excess of competitor DNA. For quantification, the intensity of the bands corresponding to
protein–DNA complexes in EMSA, obtained in the presence or absence of competitor, were quantified in a densitometer. The percentage of
inhibition was calculated as described in the Materials and Methods section. The results are the average and SD of at least three independent
experiments, with a maximal associated error of 30%.
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a Lac phenotype is displayed indicating recovery of
regulation. Thus, we screened for transformants with
decreased b-galactosidase production in the absence of
arabinose.
One transformant of strain IQB533, containing the
fusion ORA1(T6!G)–lacZ, displayed a gain-of-function
phenotype, and the sequencing of the araR allele revealed
the substitution M34T, located in the HTH motif of the
protein. To determine if this effect was specific or also
affected AraR binding to the other mutated promoters,
the allele was integrated at the thrC locus of the
corresponding B. subtilis strains and b-galactosidase
activities were measured (Figure 6A). Interestingly, the
repression exerted by mutant M34T was higher than that
exerted by wild-type AraR in almost all operators, in
particular with mutant boxes G9!T (both in ORA1 and
ORA2), T6!G, A11!C and T16!G. Since a higher level
of intracellular accumulation of this AraR variant could
explain this phenotype, we determined the accumulation
of the wild-type AraR and mutant M34T in strains
IQB572 and IQB583, respectively (Table 1). The observed
cellular levels of protein were similar in both strains
(Figure 6B), indicating that the phenotype displayed by
M34T was not due to increased concentration of protein.
In fact, EMSA assays performed as described above
showed that the mutant displays an increased affinity to
the ara operon promoter probe, with an apparent Kd of
1.0 108M (Figure 6C), which is almost 4-fold lower
than that of the wild-type protein (Kd= 3.9 108 M).
The substitution M34T is located in the first helix of the
winged HTH motif (Figure 1A). According to a study
on protein–DNA interactions based on structures of
129 complexes (32), threonine is responsible for a far
larger number of protein–DNA bonds than methionine,
although almost all are made with the DNA backbone
and not the bases. This is in agreement with the results we
obtained, that show an increase in the repression exerted
over all mutated boxes, suggesting an increased DNA
affinity of M34T through non-specific contacts.
CONCLUDING REMARKS
Previous studies have mapped the functional domains of
AraR and characterized the C-terminal region involved in
effector binding and dimerization (8). In this work, we
focused on two additional and crucial components of the
transcription process, the DBD and cis-acting elements.
Guided by molecular modelling combined with multiple
primary sequence alignment of AraR orthologues and
GntR family members, we identified amino acids poten-
tially involved in DNA binding. The effect of their
substitution was analysed in vivo and in vitro and revealed
key residues necessary for the regulatory activity. In
addition, important bases for AraR–DNA interactions in
both arms of the palindromic operator sequences were
also identified. We obtained both expected and unex-
pected results highlighting the uniqueness of protein–
DNA interactions in each particular system. A future
determination of the structure of AraR, in its unbound
form or in complex with the inducer or DNA, would allow
a more detailed analysis of the mechanism by which AraR
binds its cognate operator sequences and how the
conformational change triggered by the binding of
arabinose prevents this interaction.
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Figure 6. Characterization of suppressor mutant M34T. (A) Comparison of the repression exerted in vivo by AraR wild type or mutant M34T over
ara boxes. b-Galactosidase activities were determined in B. subtilis strains carrying the different araA–lacZ fusions integrated at the amyE locus and
the wild-type or M34T araR allele integrated at the thrC locus, grown in inducing and non-inducing conditions. The bars represent the repression
index obtained for wild-type AraR (white bars) or variant M34T (grey bars) (Figure 2). Values are the average of three independent experiments,
each assayed in duplicate. Error bars represent the SD. (B) Intracellular accumulation of AraR wild type and mutant M34T by western immunoblot
analysis from cultures grown in the absence () or presence (+) of inducer (Figure 2). (C) Binding of AraR M34T to araABDLMNPQ-abfA
promoter (operators ORA1–ORA2) in EMSA. The indicated concentrations of AraR mutant M34T were used in the binding reactions. The derived
Kd is shown below (Figure 3).
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